| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
0.85 |
| Metabolic Syndrome |
0 |
0.9 |
| Type 2 Diabetes Mellitus |
0 |
0.98 |
| Diet |
0 |
0.99 |
| Liver |
0 |
0.44 |
| Fatty Liver |
0 |
0.97 |
| Liver Disease |
0 |
0.38 |
| Liver Biopsy |
0 |
0.36 |
| Lipids Management |
0 |
0.22 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Weight Management |
0 |
0.11 |
| Biopsy |
0 |
0.1 |
| Blood |
0 |
0.06 |
| Child |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Hemoglobin A1c |
0 |
0.06 |
| Hepatitis |
0 |
0.06 |
| Metabolism |
0 |
0.06 |
| Triglycerides |
0 |
0.06 |
| Weight Loss |
0 |
0.06 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.05 |
| Medical Life |
0 |
0.05 |
| Adherence |
0 |
0.03 |
| Body Mass Index |
0 |
0.03 |
| DPP-4 Inhibitors |
0 |
0.03 |
| Exercise |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Lipoproteins |
0 |
0.03 |
| Match |
0 |
0.03 |
| Nonalcoholic Steatohepatitis |
0 |
0.03 |
| SGLT2 Inhibitor |
0 |
0.03 |
| Steatosis |
0 |
0.03 |
| UK Site Content |
0 |
0.03 |